IvorRoystonMD

Oncology • San Diego, CA

Physician

Join to view full profile

Dr. Royston is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Royston's full profile

Already have an account?

Office
9393 Towne Centre Dr
Suite 200
San Diego, CA 92121
Phone+1 858-332-3410

Fax+1 858-362-1051
Is this information wrong?

Education & Training

Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 1970 - 1972
Johns Hopkins University School of MedicineClass of 1970

Certifications & Licensure

CA State Medical License 1971 - 2025
MD State Medical License 1972 - 1977
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Elected Member The American Society for Clinical Investigation, 1984

Publications & Presentations

PubMed

3 citations
Targeted therapy with nanatinostat and valganciclovir in recurrent EBV-positive lymphoid malignancies: a phase 1b/2 study.
Bradley Haverkos, Onder Alpdogan, Robert Baiocchi, Jonathan E Brammer, Tatyana A Feldman, Marcelo Capra, Elizabeth A Brem, Santosh Nair, Phillip Scheinberg, Juliana Pe...> ;Blood Advances. 2023 Oct 24
54 citations
Interleukin 2 gene therapy of colorectal carcinoma with autologous irradiated tumor cells and genetically engineered fibroblasts: a Phase I study.
Robert E. Sobol, Daniel L. Shawler, C Carson, C. Van Beveren, Dan Mercola, Habib Fakhrai, M. A. Garrett, R Barone, P Goldfarb, R. M. Bartholomew, S Brostoff, Dennis J....> ;Clinical Cancer Research. 1999 Sep 1
19 citations
Combination of Transforming Growth Factor β Antisense and Interleukin-2 Gene Therapy in the Murine Ovarian Teratoma Model
Oliver Dorigo, Daniel L. Shawler, Ivor Royston, Robert E. Sobol, Jonathan S. Berek, Habib Fakhrai> ;Gynecologic Oncology. 1998 Nov 1
13 citations
Antigen-Specific IgG Responses from Naive Human Splenocytes: In Vitro Priming Followed by Antigen Boost in the SCID Mouse
Peter Brams, Mai-Lan Nguyen, Soulaima Chamat, Ivor Royston, Phillip R. Morrow> ;Journal of Immunology. 1998 Mar 1
509 citations
IDEC-C2B8: results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma.
David G. Maloney, Antonio J. Grillo-Lopez, D. Bodkin, Christine A. White, TM Liles, Ivor Royston, C. Varns, Jay Rosenberg, Ronald Levy> ;Journal of Clinical Oncology. 1997 Oct 1
1272 citations
IDEC-C2B8 (Rituximab) Anti-CD20 Monoclonal Antibody Therapy in Patients With Relapsed Low-Grade Non-Hodgkin's Lymphoma
David G. Maloney, Antonio J. Grillo-Lopez, Christine A. White, David Bodkin, Russell J. Schilder, James A. Neidhart, Nalini Janakiraman, Kenneth A. Foon, Tina Marie Li...> ;Blood. 1997 Sep 15
9 citations
Gene Therapy Approaches to Enhance Antitumor Immunity
Daniel L. Shawler, Habib Fakhrai, C. Van Beveren, Dan Mercola, D. P. Gold, R. M. Bartholomew, Ivor Royston, Robert E. Sobol> ;Advances in Pharmacology. 1997 Jan 1
53 citations
Radioimmunotherapy of relapsed B-cell lymphoma with yttrium 90 anti-idiotype monoclonal antibodies
Christine A. White, Samuel E. Halpern, Barbara A. Parker, Richard A. Miller, Homer B. Hupf, Daniel L. Shawler, Heli Collins, Ivor Royston> ;Blood. 1996 May 1
245 citations
Eradication of established intracranial rat gliomas by transforming growth factor beta antisense gene therapy
Habib Fakhrai, Oliver Dorigo, Daniel L. Shawler, Hong Lin, Dan Mercola, Keith L. Black, Ivor Royston, Robert E. Sobol> ;Proceedings of the National Academy of Sciences of the United States of America. 1996 Apr 2
65 citations
Cytokine Gene Therapy with Interleukin-2-Transduced Fibroblasts: Effects of IL-2 Dose on Anti-Tumor Immunity
Habib Fakhrai, Daniel L. Shawler, Ruth A. Gjerset, Robert K. Naviaux, James A. Koziol, Ivor Royston, Robert E. Sobol> ;Human Gene Therapy. 1995 May 1
24 citations
Comparison of gene therapy with interleukin-2 gene modified fibroblasts and tumor cells in the murine CT-26 model of colorectal carcinoma
Daniel L. Shawler, Oliver Dorigo, Ruth A. Gjerset, Ivor Royston, Robert E. Sobol, Habib Fakhrai> ;Journal of Immunotherapy With Emphasis on Tumor Immunology. 1995 May 1
80 citations
Interleukin-2 gene therapy in a patient with glioblastoma.
Robert E. Sobol, Habib Fakhrai, Daniel L. Shawler, Ruth A. Gjerset, Oliver Dorigo, C Carson, Khaleghi T, James A. Koziol, Shiftan Ta, Ivor Royston> ;Gene Therapy. 1995 Mar 1
8 citations
Characterization of a new human glioblastoma cell line that expresses mutant p53 and lacks activation of the PDGF pathway.
Ruth A. Gjerset, Habib Fakhrai, Daniel L. Shawler, Sally T. Turla, Oliver Dorigo, Amita Grover-Bardwick, Dan Mercola, Shu-Fen Wen, Heli Collins, Hong Lin, Marileila Va...> ;In Vitro Cellular & Developmental Biology. Animal. 1995 Mar 1
25 citations
Injection of Colon Carcinoma Patients with Autologous Irradiated Tumor Cells and Fibroblasts Genetically Modified to Secrete Interleukin-2 (IL-2): A Phase I Study. San...
Study Co-Chairs: Robert E. Sobol, Ivor Royston, Co-Investigators: Habib Fakhrai, Daniel L. Shawler, Colette Carson, Oliver Dorigo, Ruth A. Gjerset, Daniel P. Gold, Jam...> ;Human Gene Therapy. 1995 Feb 1
62 citations
Phenotypic Markers and BCL-1 Gene Rearrangements in B-Cell Chronic Lymphocytic Leukemia: A Cancer and Leukemia Group B Study
RA Newman, Bercedis Peterson, FR Davey, C Brabyn, Heli Collins, VL Brunetto, DB Duggan, R B Weiss, Ivor Royston, FE Millard> ;Blood. 1993 Aug 15
4 citations
Factors affecting production of antibodies to prostate antigens by in vitro-primed human splenocytes.
Edward W. Lu, Anna T. Bustria, Ivor Royston, Peter Brams> ;Hybridoma. 1993 Aug 1
Gene Therapy Approval Process
Ivor Royston> ;Science. 1993 Mar 19
6 citations
In vitro priming of human lymphocytes. I. IL-2 and IL-4 requirements.
Peter Brams, Ivor Royston, Paula Boernert> ;Human Antibodies and Hybridomas. 1993 Jan 1
6 citations
In vitro priming of human lymphocytes. II. Induction of antigen-specific IgG responses by repeated antigen stimulation.
Peter Brams, Ivor Royston, Paula Boerner> ;Human Antibodies and Hybridomas. 1993 Jan 1
74 citations
The effects of postinduction intensification treatment with cytarabine and daunorubicin in adult acute lymphocytic leukemia: a prospective randomized clinical trial by...
R R Ellison, Rosemarie Mick, Janet Cuttner, Celia A. Schiffer, Richard T. Silver, Edward S. Henderson, T. Woliver, Ivor Royston, Frederick R. Davey, Arvin S. Glicksman> ;Journal of Clinical Oncology. 1991 Nov 1
19 citations
Production of antigen-specific human monoclonal antibodies from in vitro-primed human splenocytes.
P. Boerner, R. Lafond, Wei-Zhao Lu, P. Brams, Ivor Royston> ;Journal of Immunology. 1991 Jul 1
17 citations
Expression of shared idiotypes in chronic lymphocytic leukemia and small lymphocytic lymphoma
Elizabeth M. Swisher, Daniel L. Shawler, Heli Collins, Anna T. Bustria, Sarah Hart, Clara Bloomfield, Richard A. Miller, Ivor Royston> ;Blood. 1991 May 1
50 citations
Radioimmunotherapy of Human B-Cell Lymphoma with 90Y-conjugated Antiidiotype Monoclonal Antibody
Barbara A. Parker, Artemios B. Vassos, Samuel E. Halpern, Richard A. Miller, Homer B. Hupf, Amox D, Joseph L. Simoni, Robin J. Starr, Mark R. Green, Ivor Royston> ;Cancer Research. 1990 Feb 1
52 citations
Shared Idiotypes Expressed by Human B-Cell Lymphomas
Richard A. Miller, Sarah Hart, Michael Samoszuk, Christine Coulter, Sherri L. Brown, Debra K. Czerwinski, Janet Kelkenberg, Ivor Royston, Ronald Levy> ;The New England Journal of Medicine. 1989 Sep 28
6 citations
Unique subset of thymic epithelial cells defined by the expression of a novel neuroendocrine antigen.
Robert E. Sobol, Douglas Burton, Marie-Therese Schaeffer, David A. Tice, Ivor Royston, Leonard J. Deftos> ;Cellular Immunology. 1988 Aug 1
Join now to see all

Abstracts/Posters

Combination of Oral Nanatinostat (Nstat), a Novel Histone Deacetylase Inhibitor (HDACi), and the Oral Anti-Viral, Valganciclovir (VGCV), Is Active in Relapsed/Refracto...
Ivor Royston, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Press Mentions

Viracta Therapeutics Reports Second Quarter 2022 Financial Results and Recent UpdatesAugust 9th, 2022
From CAR T to Liquid Biopsies: The New Cancer Research Unveiled at Annual ConferenceDecember 16th, 2021
Viracta Therapeutics Reports Second Quarter 2021 Financial Results and Provides Clinical and Corporate UpdatesAugust 12th, 2021
Join now to see all

Grant Support

Conference--Moab Immunoconjugates For CancerNational Cancer Institute1998
10th International Conference On MOAB ImmunoconjugatesNational Cancer Institute1995
Monoclonal Antibody Therapy Of B-Cell MalignancyNational Cancer Institute1993–1995
International Conference On MOAB Immunoconjugates For CANational Cancer Institute1994
2nd International Conference On Gene Therapy Of CancerNational Cancer Institute1994
Conference--Mab Immunoconjugates For CancerNational Cancer Institute1992
Monoclonal Antibodies In Cancer Detection And TreatmentNational Cancer Institute1991
Conf On Monoclonal Antibody Immunoconjugates For CancerNational Cancer Institute1991
Monocional Antibodies In Cancer Detection And TreatmentNational Cancer Institute1990
5th International Conference On MOAB ImmunoconjugatesNational Cancer Institute1990
Monoclonal Antibodies In Cancer Detection And TreatmentNational Cancer Institute1985–1990
Fourth International Conference On Monoclonal AntibodyNational Cancer Institute1989
Third International Conference On Monoclonal AntibodyNational Cancer Institute1988
Second International Conference Of Monoclonal AntibodyNational Cancer Institute1987
Monoclonal Antibodies To Human B Cell LymphomasNational Cancer Institute1985
Cell Sorting And Surface Marker Laboratory--CoreNational Cancer Institute1985
Clinical Evaluation Of Biological Response ModifiersDivision Of Cancer Treatment1985

IvorRoystonMD

Dr. Royston is on Doximity

Education & Training

Certifications & Licensure

Awards, Honors, & Recognition

Publications & Presentations

Press Mentions

Grant Support

Viewing the full profile is available to verified healthcare professionals only.